These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24494623)

  • 1. Predictors of smoking cessation medication use among nonobese and obese smokers.
    Yang M; Mehta HB; Bhowmik D; Essien EJ; Abughosh SM
    Subst Use Misuse; 2014 May; 49(6):752-61. PubMed ID: 24494623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between obesity and prescription of smoking cessation medications.
    Yu Y; Rajan SS; Essien EJ; Yang M; Abughosh S
    Popul Health Manag; 2014 Jun; 17(3):172-9. PubMed ID: 24784163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an electronic alert and order set on smoking cessation medication prescription.
    Mathias JS; Didwania AK; Baker DW
    Nicotine Tob Res; 2012 Jun; 14(6):674-81. PubMed ID: 22180576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Smoking Cessation Medications to Attenuate Weight Gain Following Cessation.
    Yang M; Chen H; Johnson ML; Essien EJ; Peters RJ; Wang X; Abughosh S
    Subst Use Misuse; 2016; 51(5):586-97. PubMed ID: 27007975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers.
    Tibuakuu M; Okunrintemi V; Jirru E; Echouffo Tcheugui JB; Orimoloye OA; Mehta PK; DeFilippis AP; Blaha MJ; Michos ED
    JAMA Netw Open; 2019 May; 2(5):e194585. PubMed ID: 31125108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Use of Medications for Smoking Cessation in Medicare, 2007-2012.
    Jarlenski M; Hyon Baik S; Zhang Y
    Am J Prev Med; 2016 Sep; 51(3):301-8. PubMed ID: 27036506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of success for smoking cessation at the workplace: a longitudinal study.
    Stolz D; Scherr A; Seiffert B; Kuster M; Meyer A; Fagerström KO; Tamm M
    Respiration; 2014; 87(1):18-25. PubMed ID: 23594795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Kotz D; Fidler JA; West R
    Nicotine Tob Res; 2011 Sep; 13(9):793-9. PubMed ID: 21543548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the use of aids to cessation in English smokers.
    Kotz D; Fidler J; West R
    Addiction; 2009 Aug; 104(8):1403-10. PubMed ID: 19549267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in primary care prescriptions of stop-smoking medication as a result of health insurance coverage in the Netherlands: population based study.
    Verbiest ME; Chavannes NH; Crone MR; Nielen MM; Segaar D; Korevaar JC; Assendelft WJ
    Addiction; 2013 Dec; 108(12):2183-92. PubMed ID: 23819654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do general medical practice characteristics influence the effectiveness of smoking cessation programs? A multilevel analysis.
    Hiscock R; Moon G; Pearce J; Barnett R; Daley V
    Nicotine Tob Res; 2012 Jun; 14(6):703-10. PubMed ID: 22193573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial.
    Fu SS; van Ryn M; Sherman SE; Burgess DJ; Noorbaloochi S; Clothier B; Taylor BC; Schlede CM; Burke RS; Joseph AM
    JAMA Intern Med; 2014 May; 174(5):671-7. PubMed ID: 24615217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Trends in Smoking Cessation Medication Prescriptions for Smokers With Chronic Obstructive Pulmonary Disease in the United States, 2007-2012.
    Kwak MJ; Kim J; Bhise V; Chung TH; Petitto GS
    J Prev Med Public Health; 2018 Sep; 51(5):257-262. PubMed ID: 30286598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
    Steinberg MB; Bover MT; Richardson DL; Schmelzer AC; Williams JM; Foulds J
    Drug Alcohol Depend; 2011 Mar; 114(1):77-81. PubMed ID: 20951511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation medication use among pregnant and postpartum smokers.
    Rigotti NA; Park ER; Chang Y; Regan S
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):348-55. PubMed ID: 18238972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding smokers' motivations to use evidence-based smoking cessation aids.
    Willems RA; Willemsen MC; Nagelhout GE; de Vries H
    Nicotine Tob Res; 2013 Jan; 15(1):167-76. PubMed ID: 22573725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helping smokers quit improves health and budgets.
    Kelley B
    NCSL Legisbrief; 2014 Jun; 22(24):1-2. PubMed ID: 24988614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.